Chromosomal & Down’s Syndrome screening

10 – 20+ weeks
Pregnant lady viewing baby scan

Down’s Syndrome & 12 week Nuchal Scan

This is my offers peace of mind for Down’s Syndrome Screening.

Sometimes the screening process is worrisome. Many women receive unnecessary high-risk results and the waiting is worst of all. We aim to strip away all the confusion about screening and provide you with the safest, most accurate and advanced screening services available so that you can relax, feeling fully informed and confident that you made the right choice.

All of our screening tests incorporate an ultrasound scan of your baby to check well-being. We also look at a number of ultrasound markers for both the risk of a chromosomal abnormality and those associated with structural problem including cardiac and spina bifida.

Non-invasive prenatal testing (NIPT)

10-20+ weeks

(Ultrasound Scan and cell free fetal DNA analysis)

1 in 30 women will be given a high risk result with the NHS combined screen but most of these babies will be normal. If you fall into this high risk group you will be offered an amniocentesis or CVS. The possibility of miscarriage now becomes a real threat. There is an alternative and it’s the best reassurance any parent would want so they can protect their unborn baby.

This new non-invasive prenatal test will detect over 99.5% of babies affected with Down’s syndrome and other chromosomal abnormality and less than 1 in 3000 women will be given a false positive screen result.

Nuchal+ screening

11-13 weeks

(Ultrasound Scan only)

The nuchal scan is the basis for screening for Down’s Syndrome and other abnormalities and measures the fluid under the skin at the back of baby’s neck as a means to identifying high-risk pregnancies.

In order to get the optimal risk assessment, Nuchal screening used in isolation to screen for chromosomal risk, is best performed in the hands of experts who specialise in screening for chromosomal abnormalities .

The NHS combined first trimester screen using nuchal scan and 2 maternal placental biochemical markers aims to detect up to 90% of pregnancies affected with Down’s syndrome but a worrying 1 in 30 women will receive a positive high-risk.

At this is my, because we check and measure more anatomical markers in addition to the Nuchal Translucency (NT) measurement, we are able to more effectively calculate risk and lower your chance of receiving a false positive result.

Currently to-date we have never failed to obtain a nuchal measurement and calculate risk assessment. Our expertise is your reassurance. Call immediately if your NHS screen has failed.

Singleton: £120
Multiple: £180

Comparison of services

  Non-invasive Prenatal Nuchal+ NHS Combined* NHS Quadruple*
  About the test
One stop service YES YES NO YES
Immediate appointment YES YES NO NO
Result availability 10+ days immediately Up to 2+ weeks Up to 2+ weeks
Gestational age 10+ weeks 11 – 13 weeks 11 – 13 weeks 14+ weeks
Fetal DNA analysis YES NO NO NO
Maternal blood mark NO NO 2 4
  Ultrasound markers
Dating scan YES YES YES YES
Nuchal translucency 11+ week scan YES YES NO
Detailed anatomy check 11+ week scan YES ? NO
Nose Bone 11+ week scan YES NO NO
Ductus Venous 11+ week scan YES NO NO
Tricuspid Flow 11+ week scan YES NO NO
Intra-cranial translucency 11+ week scan YES NO NO
  Screening for
Down’s Syndrome T21 YES YES YES YES
Edwards’ Syndrome YES YES NO NO
Patau Syndrome T13 YES YES NO NO
Down’s Detection >99% 89% up to 90% 75%
Chance of high risk result 1 in 3,000 1 in 40% 1 in 30 1 in 30
  0.01% 2.8% 2 – 3% 3%
Peace of mind from £350 £120 NHS NHS